Express News | NYSE Order Imbalance 109116.0 Shares on Buy Side
Express News | Danimer Scientific Receives Continued Listing Standard Notice From NYSE
Jefferies Downgrades Danimer Scientific(DNMR.US) to Hold Rating, Cuts Target Price to $0.8
Jefferies analyst Laurence Alexander downgrades $Danimer Scientific(DNMR.US)$ to a hold rating, and adjusts the target price from $1.3 to $0.8.According to TipRanks data, the analyst has a success rat
Danimer Scientific Price Target Cut to $0.80/Share From $1.30 by Jefferies
Danimer Scientific Price Target Cut to $0.80/Share From $1.30 by Jefferies
Jefferies Investment Bank: Downgraded the Danimer Scientific (DNMR.US) rating from buy to hold, and adjusted the target price from $1.30 to $0.80.
Jefferies Investment Bank: Downgraded the Danimer Scientific (DNMR.US) rating from buy to hold, and adjusted the target price from $1.30 to $0.80.
Danimer Scientific Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 1.01% Jefferies $1.3 → $0.8 Downgrades Buy → Hold 04/09/2024 57.83% Piper Sandler $3.5 → $1.25
Jefferies Downgrades Danimer Scientific to Hold From Buy
Jefferies Downgrades Danimer Scientific to Hold From Buy.
Cautious Outlook for Danimer Scientific Amidst Leadership Changes and Mixed Financial Signals
Danimer Scientific's CEO And Chairman Steve Croskrey Announces Retirement, To Step Down As CEO No Later Than The End Of This Calendar Year; To Exit Chairman Position May 20, 2024; Board Appoints Richard J. Hendrix As Interim CEO And New Co Chairman
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today t
Danimer Scientific Appointe Richard J. Hendrix Chmn >DNMR
Danimer Scientific Appointe Richard J. Hendrix Chmn >DNMR
Danimer Scientific CEO Steve Croskrey to Retire >DNMR
Danimer Scientific CEO Steve Croskrey to Retire >DNMR
Danimer Scientific Announces Steve Croskrey Retirement and Related Changes to the Company's Board of Directors
Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year. Mr. Croskrey's employment contract expires at the end of 2024 following nine years leading Danimer's mission to commercialize its innovative biodegradable plastic resin, Nodax PHA.
Analysts Have Conflicting Sentiments on These Materials Companies: Axalta Coating Systems (AXTA), Danimer Scientific (DNMR) and New Gold (NGD)
Danimer Scientific Files for $350M Mixed Securities Shelf
Danimer Scientific Launches New Executive Severance Plan
Danimer Scientific, Inc. (NYSE:DNMR) Just Reported And Analysts Have Been Cutting Their Estimates
Danimer Scientific First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Earnings Call Summary | Danimer Scientific(DNMR.US) Q1 2024 Earnings Conference
The following is a summary of the Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript:Financial Performance:Danimer Scientific reported a decline in its Q1 2024 total revenue to $10.2 mil
Danimer Scientific Sees FY24 Capital Expenditures $8M-$10M
Danimer Scientific Sees FY24 Capital Expenditures $8M-$10M
Danimer Scientific | 10-Q: Quarterly report